These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31672401)

  • 1. Subvisible Particles in IVIg Formulations Activate Complement in Human Serum.
    Chisholm CF; Behnke W; Pokhilchuk Y; Frazer-Abel AA; Randolph TW
    J Pharm Sci; 2020 Jan; 109(1):558-565. PubMed ID: 31672401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEHP Nanodroplets Leached From Polyvinyl Chloride IV Bags Promote Aggregation of IVIG and Activate Complement in Human Serum.
    Snell JR; Monticello CR; Her C; Ross EL; Frazer-Abel AA; Carpenter JF; Randolph TW
    J Pharm Sci; 2020 Jan; 109(1):429-442. PubMed ID: 31229435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation and Particle Formation of Therapeutic Proteins in Contact With a Novel Fluoropolymer Surface Versus Siliconized Surfaces: Effects of Agitation in Vials and in Prefilled Syringes.
    Teska BM; Brake JM; Tronto GS; Carpenter JF
    J Pharm Sci; 2016 Jul; 105(7):2053-65. PubMed ID: 27233685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
    Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
    J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic Identification of the Stress Sources of Protein Aggregates Using Flow Imaging Microscopy Images.
    Gambe-Gilbuena A; Shibano Y; Krayukhina E; Torisu T; Uchiyama S
    J Pharm Sci; 2020 Jan; 109(1):614-623. PubMed ID: 31669608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effect of syringe surfaces on protein formulations.
    Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
    J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intravenous immunoglobulin treatment activates complement in vivo.
    Mollnes TE; Høgåsen K; De Carolis C; Vaquero E; Nielsen EW; Fontana L; Perricone R
    Scand J Immunol; 1998 Sep; 48(3):312-7. PubMed ID: 9743219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
    Nagata S; Glovsky MM
    J Allergy Clin Immunol; 1987 Jul; 80(1):24-32. PubMed ID: 3496373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Nanoparticles Promote Microparticle Formation in Intravenous Immunoglobulin Solutions During Freeze-Thawing and Agitation Stresses.
    Pardeshi NN; Zhou C; Randolph TW; Carpenter JF
    J Pharm Sci; 2018 Jul; 107(7):1852-1857. PubMed ID: 29601840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Quantification of Protein Particles in High-Concentration Antibody Formulations.
    Wu H; Randolph TW
    J Pharm Sci; 2019 Mar; 108(3):1110-1116. PubMed ID: 30773198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA; Steiger G; Paccaud JP
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position.
    Seifert PS; Kazatchkine MD
    Mol Immunol; 1987 Dec; 24(12):1303-8. PubMed ID: 3431552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement deposition induced by binding of anti-contactin-1 auto-antibodies is modified by immunoglobulins.
    Appeltshauser L; Weishaupt A; Sommer C; Doppler K
    Exp Neurol; 2017 Jan; 287(Pt 1):84-90. PubMed ID: 27746185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg").
    Stangel M; Compston A; Scolding NJ
    J Neuroimmunol; 2000 Mar; 103(2):195-201. PubMed ID: 10696915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Subvisible Particle Formation in Lyophilized Intravenous Immunoglobulin Formulations Containing Polysorbate 20.
    Zhou C; Qi W; Lewis EN; Randolph TW; Carpenter JF
    J Pharm Sci; 2016 Aug; 105(8):2302-9. PubMed ID: 27290624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.
    Basta M; Van Goor F; Luccioli S; Billings EM; Vortmeyer AO; Baranyi L; Szebeni J; Alving CR; Carroll MC; Berkower I; Stojilkovic SS; Metcalfe DD
    Nat Med; 2003 Apr; 9(4):431-8. PubMed ID: 12612546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambivalent effect of immunoglobulins on the complement system: activation versus inhibition.
    Basta M
    Mol Immunol; 2008 Oct; 45(16):4073-9. PubMed ID: 18706699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.